The Claim
Theoretical modeling indicates that malic acid at physiological concentrations does not directly reduce calcium oxalate supersaturation through calcium chelation, and any observed reduction in calcium oxalate supersaturation must be mediated indirectly, likely via increased citrate.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Malic acid at normal levels in the body does not lower calcium oxalate supersaturation by binding calcium; if calcium oxalate supersaturation decreases, it is due to another mechanism involving citrate.
See the scientific wording
Theoretical modeling indicates that malic acid at physiological concentrations does not directly reduce calcium oxalate supersaturation through calcium chelation, suggesting that any observed reduction in calcium oxalate supersaturation must be mediated indirectly, likely via increased citrate.
When malic acid is consumed, it gets broken down in the body and produces a compound that makes the blood slightly less acidic. This change causes the kidneys to release more citrate into the urine. The citrate in the urine binds to calcium, leaving less free calcium available to combine with oxalate. With less free calcium, calcium oxalate cannot form crystals as easily.
What the research says
1 studyMalic acid doesn’t stick to calcium well enough in urine to stop kidney stones on its own — but it does make your body produce more citrate, and citrate does bind calcium and help prevent stones. So any benefit comes from citrate, not malic acid directly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.